Krishnamoorthi R | Bioengineering | Young Scientist Award

Published on by Young Scientists Awards

Dr. Krishnamoorthi R | Bioengineering
| Young Scientist Award

Chang Gung University | Taiwan

Dr. R. Krishnamoorthi is an accomplished researcher specializing in nanomedicine, biomaterials, and drug delivery systems, with a strong foundation in microbiology and biomedical applications. His research focuses on the development of innovative nanostructures, including silver-gold nanocomposites, bacteriocin-functionalized nanoparticles, and bioengineered hydrogels, for antimicrobial, antioxidant, anticancer, and wound-healing therapies. He has significantly contributed to interdisciplinary research integrating nanotechnology, immunomodulatory biomaterials, and probiotics for therapeutic advancement. With over 25 peer-reviewed publications in high-impact journals such as International Journal of Biological Macromolecules, Bioorganic Chemistry, and Fish & Shellfish Immunology, his cumulative impact factor exceeds 130. His current postdoctoral research at Chang Gung University, Taiwan, emphasizes microbial biosurfactants, nanoscale drug carriers, and in silico approaches for biomedical innovation. He has also contributed to the discovery and characterization of novel probiotic strains and their exopolysaccharides with potent bioactivities. Additionally, his work extends to developing green synthesis methods for metal oxide nanoparticles and investigating their electrochemical, antibacterial, and antioxidant properties. Dr. Krishnamoorthi’s research represents a synthesis of biological and material sciences aimed at sustainable, targeted, and biocompatible solutions for global healthcare challenges.

Featured Publications

Krishnamoorthi, R., Srinivash, M., Mahalingam, P. U., & Malaikozhundan, B. (2022). Dietary nutrients in edible mushroom, Agaricus bisporus and their radical scavenging, antibacterial, and antifungal effects. Process Biochemistry, 121, 10–17.

 Chinnaiah, K., Krishnamoorthi, R., Kannan, K., Sivaganesh, D., & [additional authors if any]. (2022). Ag nanoparticles synthesized by Datura metel L. leaf extract and their charge density distribution, electrochemical and biological performance. Chemical Physics Letters, 807, 140083.

 Krishnamoorthi, R., Srinivash, M., Mahalingam, P. U., Malaikozhundan, B., & [additional authors if any]. (2022). Antimicrobial, anti-biofilm, antioxidant and cytotoxic effects of bacteriocin by Lactococcus lactis strain CH3 isolated from fermented dairy products—An in vitro and in silico study. International Journal of Biological Macromolecules, 220, 291–306.

 Chinnaiah, K., Kannan, K., Krishnamoorthi, R., Palko, N., & Gurushankar, K. (2024). Nanostructured Ag/NiO composites for supercapacitor and antibacterial applications, and in-silico theoretical investigation. Journal of Physics and Chemistry of Solids, 184, 111730.

Krishnamoorthi, R., Mahalingam, P. U., & Malaikozhundan, B. (2022). Edible mushroom extract engineered Ag NPs as safe antimicrobial and antioxidant agents with no significant cytotoxicity on human dermal fibroblast cells. Inorganic Chemistry Communications, 139, 109362.

ABDALLAH ALDAHOUK | Biomedical engineering | Best Researcher Award

Published on by Young Scientists Awards

Mr. ABDALLAH ALDAHOUK l Biomedical engineering
| Best Researcher Award

Istanbul University-Cerrahpaşa | State of Palestine

Mr. ABDALLAH ALDAHOUK , the research conducted focuses on the validation and application of Monte Carlo simulation techniques using GATE (Geant4 Application for Tomographic Emission) software for modeling computed tomography (CT) imaging systems. This work aims to enhance the accuracy and efficiency of CT imaging through advanced computational modeling, allowing precise evaluation of image quality parameters and radiation dose distribution. By employing the Catphan CTP404 phantom, the study investigates the reliability of simulated data in replicating clinical imaging conditions, ensuring that virtual simulations closely mirror real-world CT performance. The research contributes to the optimization of CT imaging protocols, reduction of patient radiation exposure, and improvement of diagnostic accuracy. It further explores the integration of simulation-based calibration and validation methods in biomedical imaging, providing a framework for developing next-generation imaging systems with enhanced resolution and safety. The findings demonstrate the potential of GATE-based Monte Carlo simulations as a powerful tool for medical physicists and biomedical engineers to design, assess, and refine imaging systems without the need for extensive experimental trials. This work represents a significant advancement in computational biomedical engineering, bridging theoretical modeling and clinical imaging applications for improved healthcare diagnostics and imaging innovation.

Profile:  Orcid 

Featured Publication

Aldahouk, A. W., Sezdi, M., & Demir, M. (2026, February). Validation of GATE-based Monte Carlo simulation for clinical CT imaging using the Catphan CTP404 phantom. Radiation Physics and Chemistry, 218, 113364. https://doi.org/10.1016/j.radphyschem.2025.113364

Hamid Heydari Sheikhhossein | Medical Biotechnology | Best Researcher Award

Published on by Young Scientists Awards

Dr. Hamid Heydari Sheikhhossein | Medical Biotechnology| Best Researcher Award

PHD at University of Chieti Pescara, Italy

Hamid Heydari Sheikhhossein is a passionate Ph.D. student in Medical Biotechnology at the University of Chieti-Pescara, Italy, with expertise in nanobiotechnology, extracellular vesicles (EVs), and regenerative medicine; he is actively engaged in cancer biology research, focusing on IL‑1β‑induced exosome release in lung cancer, and contributes to translational nanomedicine through interdisciplinary collaborations, peer-reviewed publications, and teaching, seamlessly integrating biology, engineering, and clinical insights to advance personalized medicine and targeted therapy platforms.

Profile

Google Scholar

🎓 Education 

Hamid holds a Bachelor’s degree in Biology, a Master’s in Nano-biotechnology, and is currently pursuing his Ph.D. in Medical Biotechnology at the University of Chieti-Pescara; his academic foundation spans cellular biology, molecular diagnostics, targeted drug delivery systems, and regenerative therapeutics, providing him a multidisciplinary framework for advanced research; he has developed strong competencies in cancer immunobiology, nanoparticle synthesis, biomedical imaging, and organ-on-a-chip technologies, reflecting his commitment to innovation and scientific excellence in biomedicine.

💼Experience 

Hamid has academic experience as a secondary and high school teacher, contributing to science education early on, and has grown into a young researcher with expertise in EVs, nanomedicine, and cancer research; he is actively involved in 2 research projects, collaborates with top centers like CNR Napoli and Amsterdam Vesicle Center, and contributes to translational research in dental regeneration; with 15 SCI/Scopus-indexed publications, 3 editorial roles, and industry collaborations, he merges academic rigor with real-world biomedical applications.

🏆 Awards & Honors 

Hamid’s scientific contributions have earned him multiple recognitions, including editorial board roles in Nanomedicine & Nanotechnology Open Access, Cancer Insight, and IgMin-Research-STEM journals; he co-authored a book chapter (ISBN: 978-1-83767-154-0), gained a citation index of 294, and has received appreciation through international collaborations and young scientist award nominations; his membership in SETAD Nano Iran and SNEV reflects his active role in global research networks, showcasing a well-rounded and emerging scientific profile.

🔬 Research Focus 

Hamid’s research focuses on extracellular vesicles in cancer, regenerative therapies using EVs from dental stem cells, and development of multifunctional nanoparticles for drug delivery and imaging; his Ph.D. explores IL‑1β‑induced exosome release in lung cancer, advancing knowledge of tumor microenvironments and inflammation-mediated progression; his broader interests include nanobiotechnology, organ-on-a-chip platforms, exosome-based diagnostics, and translational applications bridging bench to bedside; he is committed to advancing personalized medicine through innovative bio-nano-engineered solutions.

 Conclusion

Dr. Hamid Heydari Sheikhhossein is an outstanding early-career researcher whose scientific contributions exemplify innovation, interdisciplinary integration, and translational impact. His expertise in extracellular vesicles, nanotechnology, and regenerative approaches positions him at the frontier of biomedical research. With a solid publication record, strong citation metrics, editorial roles, and active collaborations, he is exceptionally qualified for the Best Researcher Award. His work not only advances academic knowledge but also holds promise for therapeutic and diagnostic breakthroughs in cancer and tissue regeneration.

📝Publications 

📘 1. Folic acid-adorned curcumin-loaded iron oxide nanoparticles for cervical cancer

  • Year: 2022

  • Authors: M. Ramezani Farani, M. Azarian, H. Heydari Sheikh Hossein, …

  • Journal: ACS Applied Bio Materials

  • Volume/Issue: 5(3), pp. 1305–1318

  • Citations: 116

  • Link: https://doi.org/10.1021/acsabm.1c01117

📘 2. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: Stimuli-responsive carriers, co-delivery and suppressing resistance

  • Year: 2022

  • Authors: M. Ashrafizadeh, H. Saebfar, M.H. Gholami, K. Hushmandi, A. Zabolian, …

  • Journal: Expert Opinion on Drug Delivery

  • Volume/Issue: 19(4), pp. 355–382

  • Citations: 69

  • Link: https://doi.org/10.1080/17425247.2022.2041046

📘 3. Functionalization of magnetic nanoparticles by folate as potential MRI contrast agent for breast cancer diagnostics

📘 4. Injectable hyaluronic acid-based antibacterial hydrogel adorned with biogenically synthesized AgNPs-decorated multi-walled carbon nanotubes

  • Year: 2021

  • Authors: P. Makvandi, M. Ashrafizadeh, M. Ghomi, M. Najafi, HHS Hossein, A. Zarrabi, …

  • Journal: Progress in Biomaterials

  • Volume: 10, pp. 77–89

  • Citations: 26

  • Link: https://doi.org/10.1007/s40204-021-00170-3

📘 5. The influence of truncated-conical implant length on primary stability in maxillary and mandibular regions: an in vitro study using polyurethane blocks

  • Year: 2023

  • Authors: T. Romasco, P. Pignatelli, M. Tumedei, HHS Hossein, A. Cipollina, A. Piattelli, …

  • Journal: Clinical Oral Investigations

  • Volume/Issue: 28(1), Article 28

  • Citations: 14

  • Link: https://doi.org/10.1007/s00784-023-05139-w

📘 6. A Comparison of Conical and Cylindrical Implants Inserted in an In Vitro Post-Extraction Model Using Low-Density Polyurethane Foam Blocks

  • Year: 2023

  • Authors: L. Comuzzi, M. Tumedei, N. Di Pietro, T. Romasco, …

  • Journal: Materials

  • Volume/Issue: 16(14), 5064

  • Citations: 14

  • Link: https://doi.org/10.3390/ma16145064

📘 7. Exosome-Like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art

  • Year: 2024

  • Authors: H.H. Sheikhhossein, F. Iommelli, N. Di Pietro, M.C. Curia, A. Piattelli, …

  • Journal: Vaccines

  • Volume/Issue: 12(5), 519

  • Citations: 9

  • Link: https://doi.org/10.3390/vaccines12050519

📘 8. Design and construction of curcumin–loaded targeted iron oxide nanoparticles for cancer treatment

  • Year: 2017

  • Authors: H. Heydari Sheikh Hossein, A. Zarrabi, A. Zarepour

  • Journal: Journal of Babol University of Medical Sciences

  • Volume/Issue: 19(6), pp. 64–70

  • Citations: 9

 

Fabian Fries| Medicine and Dentistry | Young Scientist Award

Published on by Young Scientists Awards

Mrs. Fabian Fries| Medicine and Dentistry | Young Scientist Award

Universitätsklinikum des Saarlandes, Germany

Dr. Fabian Fries is a Senior Consultant at Saarland University Medical Center, Homburg, Germany. He specializes in ophthalmology, with extensive international experience. After completing his medical studies at Saarland University, he trained as an ophthalmology resident. Dr. Fries has also worked in various global medical centers, including in the USA, Brazil, and Germany. His research in ophthalmology has contributed to a deeper understanding of ocular diseases, particularly those associated with aniridia and keratopathy. He holds multiple certifications in medical and clinical practices.

Publication Profile

Scholar

🎓 Education

Dr. Fabian Fries completed his high school diploma (Abitur) in 2009 in Saarland, Germany. He pursued a degree in Medicine at Saarland University from 2009 to 2016, completing the State Medical Examination. Throughout his education, Dr. Fries participated in various internships and clinical rotations, including experiences at prestigious international institutions like Children’s of Alabama, USA, and Instituto de Neurologia de Curitiba, Brazil. He further honed his skills through several specialized courses and certifications.

💼 Experience

Dr. Fries’ professional journey began with medical internships in Germany. From 2016 to 2021, he worked as an ophthalmology resident at Saarland University Medical Center. He gained international exposure through internships in the USA and Brazil, before taking on the role of Senior Consultant in 2021 at the same institution. His career has focused on advancing ophthalmology care, specifically in corneal diseases and ocular surface disorders, while mentoring medical students and residents.

🏆 Awards & Honors

Dr. Fries has earned several accolades, including scholarships from Saarland University and DAAD. He also received recognition for his contributions to ophthalmology research. His work has been widely cited, and he holds an impressive H-index of 16. Dr. Fries has been awarded for his academic achievements, including participation in prestigious international conferences. His research impact is reflected in numerous publications and his status as a prominent figure in his field.

🔬 Research Focus

Dr. Fries’ research primarily addresses ocular surface disorders, with a particular focus on congenital aniridia and keratopathy. His work includes investigating the molecular mechanisms underlying corneal diseases and evaluating therapeutic options for patients with these conditions. He is dedicated to advancing the understanding of tear film dynamics, ocular surface health, and treatment efficacy in congenital diseases, contributing significantly to the field of ophthalmology.

Conclusion

Dr. Fabian Fries is a highly qualified candidate for the Young Scientist Award, with an impressive blend of clinical experience, academic rigor, and international exposure. His dedication to advancing ophthalmology through research is evident from his significant contributions to the field. While his career trajectory is already exemplary, there are opportunities for further growth by broadening the scope of his research collaborations and increasing the visibility of his work. Given his potential and the quality of his achievements, Dr. Fries is well-deserving of this prestigious recognition.

Publication Top Notes

Title: PAX6 mutational status determines aniridia-associated keratopathy phenotype
Authors: N Lagali, B Wowra, FN Fries, L Latta, K Moslemani, TP Utheim, …
Year: 2020

Title: Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations
Authors: N Lagali, B Wowra, FN Fries, L Latta, K Moslemani, TP Utheim, …
Year: 2020

Title: Abnormal neovascular and proliferative conjunctival phenotype in limbal stem cell deficiency is associated with altered microRNA and gene expression modulated by PAX6
Authors: L Latta, N Ludwig, L Krammes, T Stachon, FN Fries, A Mukwaya, …
Year: 2021

Title: Photoaging smartphone app promoting poster campaign to reduce smoking prevalence in secondary schools: the Smokerface Randomized Trial: design and baseline characteristics
Authors: TJ Brinker, J Holzapfel, TG Baudson, K Sies, L Jakob, HM Baumert, …
Year: 2016

Title: Dysfunction of the limbal epithelial stem cell niche in aniridia-associated keratopathy
Authors: U Schlötzer-Schrehardt, L Latta, A Gießl, M Zenkel, FN Fries, …
Year: 2021

Title: Expression of retinoic acid signaling components ADH7 and ALDH1A1 is reduced in aniridia limbal epithelial cells and a siRNA primary cell based aniridia model
Authors: L Latta, K Nordström, T Stachon, A Langenbucher, FN Fries, N Szentmáry, …
Year: 2019

Title: A medical student-delivered smoking prevention program, education against tobacco, for secondary schools in Germany: randomized controlled trial
Authors: TJ Brinker, AD Owczarek, W Seeger, DA Groneberg, CM Brieske, …
Year: 2017

Title: Enigmatic human tails: A review of their history, embryology, classification, and clinical manifestations
Authors: RS Tubbs, J Malefant, M Loukas, W Jerry Oakes, RJ Oskouian, FN Fries
Year: 2016

Yilu Ni | Biomaterial | Best Researcher Award

Published on by Young Scientists Awards

Assist. Prof. Dr. Yilu Ni | Biomaterial | Best Researcher Award

Assist. Prof. Dr. Yilu Ni, Chongqing Medical University, China

👩‍🔬 Assist. Prof. Dr. Yilu Ni is an accomplished researcher in materials science and biomedical engineering. She earned her PhD (2017), MD (2014), and BD (2011) from Sichuan University. Currently an Associate Professor at Chongqing Medical University, she previously served as an Assistant Professor (2020–2023) and Postdoctoral Researcher (2018–2020). Her research focuses on biomaterials, cancer immunotherapy, and regenerative medicine, leading multiple NSFC-funded projects on hydrogels, tumor vaccines, and wound healing. She has published in ACS Applied Materials & Interfaces, Biofabrication, and Biomaterials, contributing significantly to biomedical advancements. 🏆🔬

 

Publication Profile

Orcid

🎓 Educational Background

Assist. Prof. Dr. Yilu Ni has a strong academic foundation in materials science and polymer chemistry. She earned her PhD in Material Science (2017) from Sichuan University, where she focused on advanced materials research. Prior to that, she completed her MD in Polymer Chemistry & Physics (2014), gaining expertise in polymer-based applications. Her academic journey began with a BD in Applied Chemistry (2011) from the same institution, where she developed a strong foundation in chemical sciences. Her diverse educational background equips her with interdisciplinary expertise, contributing significantly to biomedical and materials research. 🎓🔬

 

🏛 Research and Academic Experience

Assist. Prof. Dr. Yilu Ni has a distinguished academic career in laboratory medicine and biomedical research. She currently serves as an Associate Professor (2023–present) at Chongqing Medical University, where she contributes to cutting-edge medical research and education. Prior to this, she worked as an Assistant Professor (2020–2023) in the same department, focusing on innovative laboratory techniques and medical applications. Her journey began as a Postdoctoral Researcher (2018–2020), gaining expertise in advanced experimental methodologies. Her progressive academic roles reflect her dedication to scientific advancements and medical innovations. 🏛🔬📚

 

🔬 Research Focus

Assist. Prof. Dr. Yilu Ni specializes in biomaterials, nanomedicine, and regenerative medicine, with a strong emphasis on cancer immunotherapy and wound healing. 🧬 Her research explores engineered nanoparticles for enhancing antitumor immune responses 🎯, cell membrane-camouflaged nanotechnology for tissue regeneration 🏥, and hydrogel-based therapies for chronic wound healing 🩹. She also investigates biomaterial-based vaccines to prevent post-surgical tumor recurrence. 🏆 Dr. Ni’s work integrates material science, immunology, and bioengineering, contributing to next-generation therapeutic strategies for cancer treatment and tissue repair. 🚀💡

 

Publication Top Notes

1️⃣ Augmenting Antitumor Immune Effects through cGAS-STING & NF-κB Crosstalk – ACS Applied Materials & Interfaces (2025) 🦠🔬
2️⃣ Cell Membrane-Camouflaged Nanoparticles for Skin Wound Healing – Biofabrication (2025) 🏥🩹
3️⃣ Homologous Cell Membrane-Based Hydrogel for Chronic Wound Healing – Materials Today Bio (2024) 💉🧪
4️⃣ Macrophage & Fibroblast Membranes Synergize for Wound Healing – Bioengineering & Translational Medicine (2022) 🔄🧫
5️⃣ Macrophage-Derived Implantable Vaccine Prevents Tumor Recurrence – Biomaterials (2021) 🎯🧬